USFDA issues warning letter to Kilitch Healthcare India for GMP violations | Health News
[ad_1] 2 min read Last Updated : Apr 11 2024 | 5:50 PM IST The United States Food and Drug Administration (USFDA) has issued a warning letter to Mumbai-based pharmaceutical company Kilitch Healthcare India for violating Central Good Manufacturing Practices (CGMP) regulations at its Navi Mumbai plant. The USFDA based the letter on … Read more